Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

1. A method for tissue regeneration of an organ or for stimulating the generation of tissue growth in a subject in need of tissue regeneration, wherein the subject is not in need of a treatment of fibrosis, the method comprising administering to the subject a compound represented by Formula I or a pharmaceutically acceptable salt thereof, or a combination thereof:

wherein

A is C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C(O)—(CH 2 ) n —CH 3 or CH(OH)—(CH 2 ) n —CH 3 wherein n is 3 or 4;

R 1 is H, F or OH;

R 2 is H, F OH, C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C(O)—(CH 2 ) n —CH 3 or CH(OH)—(CH 2 ) n —CH 3 wherein n is 3 or 4;

R 3 is H, F, OH or CH 2 Ph;

R 4 is H, F or OH;

Q is

1) (CH 2 ) m C(O)OH wherein m is 1 or 2,

2) CH(CH 3 )C(O)OH,

3) C(CH 3 ) 2 C(O)OH,

4) CH(F)—C(O)OH,

5) CF 2 —C(O)OH, or

6) C(O)—C(O)OH; and

wherein the organ that is regenerated or the tissue that is stimulated to grow is selected from the group consisting of heart, liver, lung, skin, stomach, intestine, muscle or cartilage.

2. The method of claim 1 , wherein A is C 5 alkyl or C 6 alkyl.

3. The method of claim 1 , wherein R 2 is H, F, OH, C 5 alkyl or C 6 alkyl.

4. The method of claim 1 , wherein R 3 is H, OH or CH 2 Ph.

5. The method of claim 1 , wherein Q is (CH 2 ) m C(O)OH where m is 1 or 2.

6. The method of claim 1 , wherein A is C 5 alkyl or C 6 alkyl; R 1 is H, F or OH; R 2 is H, F, OH, C 5 alkyl or C 6 alkyl; R 3 is H, OH or CH 2 Ph; R 4 is H, F or OH; and Q is (CH 2 ) m C(O)OH where m is 1 or 2.

7. The method of claim 1 , wherein A is C 5 alkyl; R 1 is H; R 2 is H or C 5 alkyl; R 3 is H; R 4 is H; and Q is (CH 2 ) m C(O)OH where m is 1.

8. The method of claim 1 , wherein said compound is selected from the group consisting of the compounds represented by the following structures:

and pharmaceutically acceptable salts thereof.

9. The method of claim 1 , wherein said compound is represented by the following structure:

or pharmaceutically acceptable salt thereof.

10. The method of claim 1 , wherein said compound is represented by the following structure:

or pharmaceutically acceptable salt thereof.

11. The method of claim 1 , wherein the pharmaceutically acceptable salt is a base addition salt comprising a metal counterion selected from the group consisting of sodium, potassium, calcium, magnesium, lithium, ammonium, manganese, zinc, iron, or copper.

12. The method of claim 1 , wherein the pharmaceutically acceptable salt is a sodium salt.

13. The method of claim 1 , wherein the organ is an injured organ.

14. A method for modulating the expression of a tissue self-repair marker or a tissue regeneration marker in a cell or an organ of a subject, wherein the cell or organ is not fibrotic and the cell or organ is selected from the group consisting of heart, liver, lung, skin, stomach, intestine, muscle and cartilage, the method comprising the step of administering to a subject in need of tissue regeneration a compound represented by Formula I or a pharmaceutically acceptable salt thereof, or a combination thereof:

wherein

A is C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C(O)—(CH 2 ) n —CH 3 or CH(OH)—(CH 2 ) n —CH 3 wherein n is 3 or 4;

R 1 is H, F or OH;

R 2 is H, F, OH, C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C(O)—(CH 2 ) n —CH 3 or CH(OH)—(CH 2 ) n —CH 3 wherein n is 3 or 4;

R 3 is H, F, OH or CH 2 Ph;

R 4 is H, F or OH;

Q is

1) (CH 2 ) m C(O)OH wherein m is 1 or 2,

2) CH(CH 3 )C(O)OH,

3) C(CH 3 ) 2 C(O)OH,

4) CH(F)—C(O)OH,

5) CF 2 —C(O)OH, or

6) C(O)—C(O)OH; and

wherein the tissue self-repair marker or the tissue regeneration marker is expressed in the heart, liver, lung, skin, stomach, intestine, muscle or cartilage.

15. The method of claim 14 , wherein the marker is a metalloproteinase or a growth factor.

16. The method of claim 14 , wherein the marker is hepatocyte growth factor (HGF) or Serpin A1 (AAT).

17. A method for treating a physical injury in an organ or tissue in a subject in need of tissue regeneration, wherein the organ or tissue is not fibrotic and is selected from the group consisting of heart, liver, lung, skin, stomach, intestine, muscle and cartilage, the method comprising contacting the organ or tissue with an effective amount of a compound represented by Formula I or a pharmaceutically acceptable salt thereof, or a combination thereof:

wherein

A is C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C(O)—(CH 2 ) n —CH 3 or CH(OH)—(CH 2 ) n —CH 3 wherein n is 3 or 4;

R 1 is H, F or OH;

R 2 is H, F, OH, C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C(O)—(CH 2 ) n —CH 3 or CH(OH)—(CH 2 ) n —CH 3 wherein n is 3 or 4;

R 3 is H, F, OH or CH 2 Ph;

R 4 is H, F or OH;

Q is

1) (CH 2 ) m C(O)OH wherein m is 1 or 2,

2) CH(CH 3 )C(O)OH,

3) C(CH 3 ) 2 C(O)OH,

4) CH(F)—C(O)OH,

5) CF 2 —C(O)OH, or

6) C(O)—C(O)OH; and

wherein said contacting treats the physical injury to the heart, liver, lung, skin, stomach, intestine, muscle or cartilage.

18. The method of claim 17 , wherein the physical injury comprises a wound and said treating comprises promoting wound healing.

19. A method for treating aging of skin in a subject in need of an anti-aging treatment due to UV exposure, climatic conditions exposure, pollution exposure, alcohol consumption or smoking, the method comprising administering to the skin of the subject an effective amount of a compound represented by Formula I or a pharmaceutically acceptable salt thereof, or a combination thereof:

wherein

A is C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C(O)—(CH 2 ) n —CH 3 or CH(OH)—(CH 2 ) n —CH 3 wherein n is 3 or 4;

R 1 is H, F or OH;

R 2 is H, F, OH, C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C(O)—(CH 2 ) n —CH 3 or CH(OH)—(CH 2 ) n —CH 3 wherein n is 3 or 4;

R 3 is H, F, OH or CH 2 Ph;

R 4 is H, F or OH;

Q is

1) (CH 2 ) m C(O)OH wherein m is 1 or 2,

2) CH(CH 3 )C(O)OH,

3) C(CH 3 ) 2 C(O)OH,

4) CH(F)—C(O)OH,

5) CF 2 —C(O)OH, or

6) C(O)—C(O)OH.